Intellia therapeutics could be worth trillion
Nettet6. sep. 2024 · In June 2024, Intellia Therapeutics had US$529m in cash, and was debt-free. In the last year, its cash burn was US$181m. So it had a cash runway of about 2.9 years from June 2024. Notably,... Nettet31. aug. 2024 · Aug. 31, 2024 1:48 PM ET Intellia Therapeutics, Inc. (NTLA) 3 Comments 7 Likes. Edmund Ingham. ... That is why the market can value a company like Intellia …
Intellia therapeutics could be worth trillion
Did you know?
Nettet1. mar. 2024 · Crispr Therapeutics AG has shed nearly two-thirds of its value since a recent peak in June. The company said Monday its programs will continue to advance and aren’t affected by the ruling. Investors appear to be valuing biotechnology companies as businesses rather than exciting ideas, and Intellia is no exception, said Brad Loncar, … Nettet2. mar. 2024 · Intellia shares have shed more than half their market value since hitting a 52-week high in September. Crispr Therapeutics AG has shed nearly two-thirds of its …
NettetIntellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic. Our company’s unique strengths … Nettet14. jan. 2024 · Stocks of start-ups wielding tools like Crispr-Cas9 that allow companies to edit DNA and attack genetic diseases and cancer are suddenly hot. But the science is …
Nettet1. apr. 2024 · Intellia Therapeutics (NASDAQ:NTLA) PT Lowered to $79.00 - MarketBeat S&P 500 4,109.31 DOW 33,274.15 QQQ 320.93 2 charged with cutting wires; 40,000 lose internet service "Prepare for Five Years of Famine" (Ad) Saudis, other oil giants announce surprise production cuts Nettet3. mar. 2024 · Intellia's market valuation has fallen by more than half since it peaked last year, but the company's market cap is still up around $5.9 billion. That's a lot for a …
Nettet12 timer siden · Are you looking for some growth stocks than can double in value? Two stocks that analysts appear to be bullish on right now are Intellia Therapeutics (NTLA …
Nettet8. apr. 2024 · Sat., April 8, 2024 MarketBeat. Gratus Capital LLC bought a new stake in Intellia Therapeutics, Inc. ( NASDAQ:NTLA - Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 67,311 shares of the company's stock, valued at … oth what to eatNettet1. jan. 2024 · Australia markets open in 7 hours 18 minutes. ALL ORDS. 7,520.70 oth wifiNettet23. mar. 2024 · Auvelity could be a blockbuster drug in treating depression, with peak annual sales -- the highest dollar volume of sales per year projected by analysts -- estimated at $2.6 billion. The peak... oth weiden duales studiumNettet3. feb. 2024 · CAMBRIDGE, Mass., Feb. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. ... the therapeutic value and development potential of CRISPR genome editing technologies and therapies, ... oth windows 10Nettet10. jul. 2024 · Healthcare is undergoing a genomics revolution, and Intellia Therapeutics (NASDAQ: NTLA) is leading the way. Founded by Jennifer Doudna, who won the 2024 Nobel Prize in Chemistry for her... oth wisNettet19. des. 2024 · Last month, Benchmark analyst Aydin Huseynov wrote that Intellia Therapeutics ( NTLA) and Alnylam ( ALNY) could be potential Regeneron (NASDAQ: REGN) targets, adding that ALNY would likely... othy104Nettet9. apr. 2024 · By selling US$762k worth of Intellia Therapeutics, Inc. (NASDAQ:NTLA) stock at an average sell price of US$37.61 over the last year, insiders seemed to have made the most of their holdings.After the stock price dropped 3.5% last week, the company's market value declined by US$115m, but insiders were able to mitigate their … oth weather